Literature DB >> 7249793

Penetration of 14C-Ro 13-9904 into tissue cage fluid in rabbits.

C Henning, S E Holm.   

Abstract

The pharmacokinetics of Ro 13-9904/001 following i.v. injection of 40 mg/kg was studied in a tissue cage model in rabbits. Binding to rabbit serum proteins was determined by ultrafiltration and found to be 98% at a concentration of 100 microgram/ml. In the early post-injection period concentrations of the drug in rabbit serum reached 500-900 microgram/ml, the antibiotic binding capacity of serum proteins was exceeded and the outflow of drug into the tissues was high. Tissue cage fluid (TCF) concentrations increased during 4h, such as to reach a maximum level of about 30 microgram/ml. After 8 h a t1/2 of 15 h was calculated both in serum and TCF. From 36 h onwards the t1/2 was 75 h. After a single injection of 14C-Ro 13-9904/001 radiological activity could be followed in serum and TCF for 7-10 days and in urine for more than 2 weeks. The results are discussed and compared to those from similar experiments with benzylpenicillin and flucloxacillin.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7249793     DOI: 10.1159/000238026

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  4 in total

1.  Reduction in biliary excretion of ceftriaxone by diclofenac in rabbits.

Authors:  M Merle-Melet; N Seta; R Farinotti; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

2.  Static and dynamic properties of tissue cage fluid in rabbits.

Authors:  A M Bergholm; C Henning; S E Holm
Journal:  Eur J Clin Microbiol       Date:  1984-04       Impact factor: 3.267

3.  Single daily dosing of antibiotics: importance of in vitro killing rate, serum half-life, and protein binding.

Authors:  G Potel; N P Chau; B Pangon; B Fantin; J M Vallois; F Faurisson; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

Review 4.  Clinical pharmacokinetics of ceftriaxone.

Authors:  J H Yuk; C H Nightingale; R Quintiliani
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.